Skip to main content

Caligan Partners LP's Form 4 filing

Standard Biotools Inc. (LAB) · filed May 2, 2022

Accession no.
0000902664-22-002740
Filed
May 2, 2022, 7:44 PM ET
Trade date
Apr 28-May 2, 2022
Filing delay
4 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market purchases total $1.08M. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Caligan Partners LPCIK 000172749210% Owner
Johnson David EdwardCIK 000178555710% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Apr 28, 2022Common Stock, $0.001 par value per share ("Common Stock")PPurchaseAcquired+27,600$2.40+$66,2409,112,438Indirect
Apr 29, 2022Common StockPPurchaseAcquired+247,400$2.66+$658,0849,359,838Indirect
May 2, 2022Common StockPPurchaseAcquired+125,000$2.81+$351,2509,484,838Indirect

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)